Sign In
Buy OPRX
$4.95
-0.330 (-6.25%)
At Close: Jun 03, 2026
OptimizeRx Named to Financial Times ―The Americas' Fastest-Growing Companies List for the Second Consecutive Year
07:51am, Tuesday, 13'th Apr 2021
Ranked #277, highlighting the growth potential and convergence between technology and healthcare Ranked #277, highlighting the growth potential and convergence between technology and healthcare
2 Biotech Stocks That Could Be Millionaire Makers
06:15am, Sunday, 04'th Apr 2021
Why OptimizeRx and Ontrak might make you rich.
OptimizeRx to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021
07:31am, Wednesday, 03'rd Mar 2021
ROCHESTER, Mich., March 03, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invit
OptimizeRx Corp. (OPRX) Soars 12%: Is Further Upside Left in the Stock?
06:04am, Tuesday, 02'nd Mar 2021
OptimizeRx Corp. (OPRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength dow
1 Under-the-Radar Stock For Healthcare Investors to Buy Now
06:00pm, Friday, 26'th Feb 2021
OptimizeRx is disrupting the pharmaceutical sales call with an internet option for marketing drugs to doctors.
OptimizeRx Corporation (OPRX) CEO William Febbo on Q4 2020 Results - Earnings Call Transcript
10:21pm, Wednesday, 24'th Feb 2021
OptimizeRx Corporation (OPRX) CEO William Febbo on Q4 2020 Results - Earnings Call Transcript
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Surpass Estimates
06:12pm, Wednesday, 24'th Feb 2021
OptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of 6.67% and 2.53%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per Share
04:01pm, Wednesday, 24'th Feb 2021
ROCHESTER, Mich., Feb. 24, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported result
OptimizeRx's Angelo Campano Named to MM+M 40 Under 40 List
07:31am, Tuesday, 23'rd Feb 2021
List Celebrates Accomplished Young Talent in Medical Marketing List Celebrates Accomplished Young Talent in Medical Marketing
OptimizeRx Sets Fourth Quarter and Full Year 2020 Conference Call for Wednesday, February 24, 2021 at 4:30 p.m. ET
07:31am, Thursday, 18'th Feb 2021
ROCHESTER, Mich., Feb. 18, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold
OptimizeRx to Present at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021
07:31am, Tuesday, 16'th Feb 2021
ROCHESTER, Mich., Feb. 16, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been
OptimizeRx Snags Equity Capital Raise of $65.6M
12:31pm, Tuesday, 09'th Feb 2021
OptimizeRx Corporation (NASDAQ: OPRX) prices its previously announced underwritten public offering of 1.325 million common shares, at $49.50 per share, raising $65.6 million in gross proceeds. Und
OptimizeRx Announces Pricing of Public Offering of Common Stock
09:10am, Tuesday, 09'th Feb 2021
ROCHESTER, Mich., Feb. 09, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX) (“OptimizeRx”), a leading provider of digital health solutions for life science companies, physicians and
OptimizeRx Announces Proposed Public Offering of Common Stock
04:18pm, Monday, 08'th Feb 2021
ROCHESTER, Mich., Feb. 08, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX) (“OptimizeRx”), a leading provider of digital health solutions for life science companies, physicians and
OptimizeRx's (OPRX) Shares March Higher, Can It Continue?
12:06pm, Thursday, 04'th Feb 2021
As of late, it has definitely been a great time to be an investor in OptimizeRx (OPRX).
